Marco Metra to Cost-Benefit Analysis
This is a "connection" page, showing publications Marco Metra has written about Cost-Benefit Analysis.
Connection Strength
0.087
-
What will be the impact of sacubitril/valsartan in clinical practice? J Cardiovasc Med (Hagerstown). 2018 Feb; 19 Suppl 1:e88-e90.
Score: 0.087
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.